LSC Webinars

  1. Solving The Inhalation Puzzle: A CDMO's Guide To Dry Powder Development 7/9/2025

    Gain guidance on the choice of formulation, excipients, and the micronization technologies offered by CDMOs, and learn about current encapsulation technologies for inhaled products.

  2. CRISPR Meets LNPs: A New Era In Cell And Gene Therapies 7/8/2025

    Explore how lipid nanoparticles are revolutionizing non-viral gene editing with scalable, efficient delivery for both ex vivo and in vivo applications, which features new CRISPR-LNP data in T cells.

  3. Transposase-Enabled CLD: From Transfection To High Titer With Ease 6/30/2025

    Gain insight into the benefits of a next-generation CLD platform that delivers consistent quality, scalable performance and flexible expression solutions tailored to the demands of complex molecules.

  4. Scaling Up Your E. Coli pDNA Process From Parameter Screening To Pilot Scale 6/26/2025

    Discover a systematic approach to scalable plasmid DNA production using E. coli OneShot Top10, which features DOE-driven optimization and key insights for efficient biomanufacturing success.

  5. The Pathway To Operational Readiness 6/24/2025

    Ready to ensure your facilities, systems, and teams are prepared for success from Day One? Discover a proven framework to accelerate operational readiness, mitigate risks, and achieve sustainable results.

  6. Navigating The New USP Chapter <382> For Elastomeric Closures 6/24/2025

    Dive into the scope of <382> for pharmaceutical closures and the regulatory landscape, which includes new required tests, instrumentation for compliance, and recommendations on implementation.

  7. Unlocking Efficiency In Large-Scale Microbial Manufacturing 6/16/2025

    Gain insights into how expert teams and the right tools help build resilience into manufacturing systems and tackle small, often-overlooked issues before they become costly problems.

  8. The Role Of Developability In Lead Candidate Selection 6/12/2025

    Discover how developability assessments are crucial for identifying biologic candidates that are both effective and manufacturable, thereby reducing risks and improving the chances of clinical success.

  9. Optimizing The Progression Of Biotherapeutic Candidates To FIH Studies 6/9/2025

    Learn actionable strategies that can lead to higher success rates and smarter resource investment, paving the way for a successful path to IND submissions and commercialization.

  10. A New Look At Subcutaneous mAb Delivery Using Nanoformed Particles 6/3/2025

    A highly concentrated non-aqueous suspension of an IgG1 was developed using a patented platform. Review how the particle size of the mAb impacts the overall behavior of the drug product.